Intellectual Property India Publishes Patent Application for 'Myeloid Lineages Derived From Pluripotent Cells' Filed by Garuda Therapeutics, Inc.

MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517043448 A) filed by Garuda Therapeutics, Inc., Cambridge, U.S.A., on May 5, for 'myeloid lineages derived from pluripotent cells.'

Inventor(s) include Shah, Dhvanit.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides for efficient ex vivo processes for generating myeloid cell lineages from human induced pluripotent stem cells (iPSCs). Cells generated according to the disclosure in various embodiments are functional and/or more closely resemble the corresponding lineage isolated from peripheral blood, bone marrow, or other tissues. The present invention in some aspects provides isolated cells and cell compositions produced by the methods disclosed herein, as well as methods for cell therapy."

The patent application was internationally filed on Oct. 05, 2023, under International application No.PCT/US2023/076109.

Disclaimer: Curated by HT Syndication.